Evidence map›Paper›PMID 40742258›Full record

ArticleFuture science OA2025

Knowledge, attitudes, and barriers regarding health promotion of ovarian cancer among community pharmacists in Jordan.

Khaled Alrosan, Mohanad Odeh, Tahani Alwidyan, Amjad Z Alrosan, Saba Madae'en

Abstract read
In one paragraph

Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khaled AlrosanDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.ORCID 0000-0001-5507-8938
Mohanad OdehDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.
Tahani AlwidyanDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.
Amjad Z AlrosanDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.
Saba Madae'enDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

methodsAn internet-based self-administrated questionnaire was distributed to community pharmacists in Jordan (n = 194) with a response rate of 53.9% through an online platform.

resultsAbout 75.2% of the community pharmacists had insufficient knowledge score of ovarian cancer and 58.2% had a higher-positive attitude. There was a significant association between the community pharmacist knowledge score and the work status or the education level (p < 0.05). The perceived lack of pharmacist' s knowledge and the absence of a private area in pharmacies for confidential conversations represent the major barriers (72.1% and 69.6%, respectively).

conclusionDespite limited knowledge about the symptoms and risk factors of ovarian cancer, as well as barriers hindering the full realization of community pharmacists' roles, they demonstrated a positive attitude toward educating patients about ovarian cancer health.

Indexed as

attitudebarriersJordanian community pharmacistsKnowledgeovarian cancer

Identifiers

PMID40742258
PMCPMC12320827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.